Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized Study Evaluating the Long-term Effects of Metoprolol (MET) Versus Nebivolol (NEB) as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension

NCT00142584 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.

NCT NCT00142584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized Study Evaluating the Long-term Effects of Metoprolol (MET) Versus Nebivolol (NEB) as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension
Lead sponsor
Mylan Bertek Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
March 31, 2008
Enrollment
336 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension